# SAXAGLIPTIN
> **ANDA205994** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2023-07-31
## Drug
- **FDA Application Number:** ANDA205994
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN
- **Generic name:** SAXAGLIPTIN
- **Active ingredients:** SAXAGLIPTIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2023-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205994)
---
*MORVS · CC0 1.0*